The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen

Current Pain and Headache Reports

Volumn 13, Issue 5, 2009, Pages 404-412

  Peterlin, B Lee ^a   Katsnelson, Michael J ^a   Calhoun, Anne H ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FLUOXETINE; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE; ANXIETY DISORDER; CHILD ABUSE; CHRONIC DAILY HEADACHE; CHRONIC DISEASE; COMORBIDITY; COST OF ILLNESS; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DRUG MECHANISM; ESTROGEN DEFICIENCY; GENERALIZED ANXIETY DISORDER; HORMONAL THERAPY; HORMONE ACTION; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MOOD DISORDER; NONHUMAN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SEXUAL ABUSE; TREATMENT RESPONSE;

COMORBIDITY; DEPRESSIVE DISORDER; ESTROGENS; HUMANS; MIGRAINE DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL;

EID: 70349634218     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-009-0066-1     Document Type: Review

References (69)

1. Bigal M, Liberman JN, Lipton R: Age-dependent prevalence and clinical features of migraine. Neurology 2006, 67:246-251.
2. Scher AI, Stewart WF, Ricci JA, Lipton RB: Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003, 106:81-89.
3. Peterlin BL, RosTo AL, Rapoport AM, Scher AI: Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 2009(in press).
4. Peterlin BL, Ward TN: Neuropsychiatric aspects of migraine. Curr Psychiatry Rep 2005, 7:371-375.
5. Peterlin BL, Ward T, Lidicker J, et al.: A retrospective, comparative study on the frequency of abuse in migraine and chronic daily headache. Headache 2007, 47:397-401.
6. Tietjen GE, Herial NA, Hardgrove J, et al.: Migraine comorbidity constellations. Headache 2007, 47:857-865.
7. De Leeuw R, Schmidt JE, Carlson CR: Traumatic stressor and post-traumatic stress disorder symptoms in headache patient. Headache 2005, 45:1365-1374.
8. Peterlin BL, Tietjen GE, Brandes JL, et al.: Posttraumatic stress disorder in migraine. Headache 2009, 49:541-551.
9. Radat F, Swendsen J: PsychiatriA comorbidity in migraine: a review. Cephalalgia 2004, 25:165-178.
10. Soares CN, Poitras JR, Prouty J: Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 2003, 20:85-100.
11. Riolo SA, Nguyen TA, Greden JF, et al.: Prevalence of depression by race/ ethnicity: Findings from the National Health and Nutrition Examination Survey III. Am J Public Health 2005, 95:998-1000.
12. Breslau N, Schultz LR, Stewart WF, et al.: Headache and major depression: Is the association specific to migraine? Neurology 2000, 54:308-314.
13. Merikangas KR, Angst J, Rsler H: Migraine and psychopathology: results of the Zurich Cohort Study of Young Adults. Arch Gen Psychiatry 1990, 47:849-853.
14. Breslau N, Lipton RB, Stewart WF, et al.: Comorbidity of migraine and depression. Neurology 2003, 60:1308-1312.
15. McWilliams LA, Goodwin RD, Cox BJ: Depression and anxiety associated with three pain conditions: Results from a nationally representative sample. Pain 2004, 111:77-83.
16. Tietjen GE, Brandes JL, Digre KB, et al.: High prevalence of somatic symptoms and depression in women with disabling chronic headache. Neurology 2007, 68:134-140.
17. Lanteri-Minet M, Radat F, Chatuard M, Lucas C: Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life and acute migraine management. Pain 2005, 319-326.
18. Molgat CV, Patten SB: Comorbidity of majAr depression and migraine: a Canadian population-based study. Can J Psychiatry 2005, 50:832-837.
19. Jette N, Patten S, William J, et al.: Comorbidity of migraine and psychiatric disorders: A national population-based study. Headache 2008, 48:501-516.
20. Patel NV, Bigal ME, Kolodner KB, et al.: Prevalence and impact of migraine and probable migraine in a health plan. Neurology 2004, 63:1432-1438.
21. Oedegaard KJ, Neckelmann D, Mykletun A, et al.: Migraine with and without aura: Association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 2006, 26:1-6.
22. Samaan Z, Farmer AE, Craddock N, et al.: A case-control study of migraine in recurrent depression. Br J Psychiatry 2009 (in press).
23. Camarda C, Pipia C, Taglialavori A, et al.: Comorbidity between depressive symptoms and migraine: Preliminary data from the Zabut Aging Project. Neuro Sci 2008, 29:S149-S1451.
24. Breslau N, Davis GC, Schultz LR, et al.: Joint 1994 Wolff Award Presentation. Migraine and major depression: A longitudinal study. Headache 1994, 34:387-393.
25. Kessler RC, Berglund P, Demler O, et al.: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
26. Kessler RC, Chiu WT, Demler O, Walters EE: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:617-627.
27. Vesga-López O, Schneier FR, Wang S, et al.: Gender differences in generalized anxiety disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry 2008, 69:1606-1616.
28. Breslau N, Davis GC: Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiat Res 1993, 27:211-221.
29. Zwart JA, Dyb G, Hagen K, et al.: Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Study. Eur J Neurol 2003, 10:147-152.
30. Tan HJ, Suganthi C, Dhachayani S, et al.: The coexistence of anxiety and depressive personality traits in migraine. Singapore Med J 2007, 48:307-310.
31. Pesa J, Lage MJ: The medical costs of migraine and comorbid anxiety and depression. Headache 2004, 44:562-570.
32. Butterfield MI, Becker M, Marx CE: Post-traumatic stress disorder in women: Current concepts and treatments. Curr Psychiatry Rep 2002, 4:474-486.
33. Goodwin RD, Hoven CW, Murison R, Hotopf M: Association between childhood physical abuse and gastrointestinal disorders and migraine in adulthood. Am J Public Health 2003, 93:1065-1067.
34. Tietjen GE, Brandes JL, Digre KB, et al.: History of childhood maltreatment is associated with comorbid depression in women with migraine. Neurology 2007, 69:959-968.
35. Saunders K, Merikangas K, Low NCP, et al.: Impact of comorbidity on headache-related disability. Neurology 2008, 70:538-547.
36. de Leeuw R, Schmidt JE, Carlson CR: Traumatic stressors and post-traumatic stress disorder symptoms in headache patients. Headache 2005, 45:1365-1374.
37. Grigoriadis S, Kennedy SH: Role of estrogen in the treatment of depression. Am J Therapeutics 2002, 9:503-509.
38. MacGregor EA: Headache and hormone replacement therapy in the postmenopausal woman. Curr Treat Options Neurol 2009, 11:10-17.
39. Dalton K: Menstruation and acute psychiatric illnesses. BMJ 1959, 34:148-149.
40. Somerville BJ: The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22:3655-3665.
41. Weissman MM, Bland RC, Canino GJ, et al.: Cross-national epidemiology of depression and bipolar disorder. JAMA 1996, 276:293-299.
42. Thorpe L, Whitney DK, Kutcher SP, et al.: Clinical guidelines for the treatment of depressive disorders VI. Special populations. Can J Psychiatry 2001, 46:S63-S67.
43. Easterbrook CC: Organo-therapeutics in mental disease. BMJ 1900, 2:813-823.
44. Soares CN, Almeida OP, Joffe H, et al.: Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001, 58:529-534.
45. Schmidt PJ, Nieman L, Danaceau MA, et al.: Estrogen replacement in perimenopause-related depression: A preliminary report. Am J Obstet Gynecol 2000, 183:414-420.
46. Klaiber EL, Broverman DM, Vogel W, et al.: Estrogen therapy for severe persistent depression in women. Arch Gen Psychiatry 1979, 36:550-554.
47. Campbell S, Whitehead M: Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977, 4:31-47.
48. Coope J: Is oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract 1981, 31:134-140.
49. Schmidt PJ, Roca CA, Bloch M, et al.: The perimenopause and affective disorders. Semin Reprod Endocrinol 1997, 15:91-100.
50. Cohen LS, Soares CN, Poitras JR, et al.: Short-term use of estradiol for depression in perimenopausal and postmenopausal women: A preliminary report. Am J Psychiatry 2003, 160:1519-1522.
51. Shapira B, Oppenheim G, Zohar J, et al.: Lack of efficacy of estrogen supplementation to imipramine in resistant depressives. Biol Psychiatry 1985, 20:570-583.
52. Schneider LS, Small GW, Hamilton SH, et al.: Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 1997, 5:97-106.
53. Amsterdam J, Garcia-Espana F, Fawcett J, et al.: Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord 1999, 55:11-17.
54. Schneider LS, Small GW, Clary CM: Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am j Geriatr Psychiatry 2001, 9:393-399.
55. Saper JR, Silberstein SD, Lake AE 3rd, Winters ME: Double-blind trial of fluoxetine: Chronic daily headache and migraine. Headache 1994, 34:497-502.
56. Ziegler DK, Hurwitz A, Preskorn S, et al.: Propranolol and amitriptyline in prophylaxis of migraine: Pharmacokinetic and therapeutic effects. Arch Neurol 1993, 50:825-830.
57. Martin VT, Behbehani M: Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis: Part I. Headache 2006, 46:3-23.
58. Denuelle M, Fabre N, Payoux P, et al.: Hypothalamic activation in spontaneous migraine attacks. Headache 2007, 47:1418-1426.
59. Solomon MB, Herman JP: Sex difOerences in psychopathology: of gonads, adrenals and mental illness. Physiol Behav 2009, 97:250-258.
60. Walf AA, Frye CA: A review and update of mechanisms of estrogen in the hippocampus and amygdale for anxiety and depression behavior. Neuropsychopharmacology 2006, 31:1097-1111.
61. Dieudonné MN, Leneveu MC, Giudicelli Y, et al.: Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol 2004, 286:C655-C661.
62. Pedersen SB, Bruun JM, Hube F, et al.: Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: Influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol 2001, 182:27-37.
63. Mather AA, Cox BJ, Enns MW, Sareen J: Associations of obesity with psychiatric disorder and suicidal behaviours in a nationally representative sample. J Psychosom Res 2009, 66:277-285.
64. Rivenes AC, Harvey SB, Mykletun A: The relationship between abdominal fat, obesity, and common mental disorders: Results from the HUNT study. J Psychosom Res 2009, 66:269-275.
65. Pulkki-Råback L, Elovainio M, Kivimäki M, et al.: Depressive symptoms and the metabolic syndrome in childhood and adulthood: A prospective cohort study. Health Psychol 2009, 28:108-116
66. Noll JG, Zeller MH, Trickett PK, Putnam FW: Obesity risk for female victims of childhood sexual abuse: A prospective study. Pediatrics 2007, 120:e61-e67.
67. King TK, Clark MM, Pera V: History of sexual abuse and obesity treatment outcome. Addict Behav 1996, 21:283-290.
68. Tietjen GE, Peterlin BL, Brandes JL, et al.: Depression and anxiety: effect on the migraine-obesity relationship. Headache 2007, 47:866-875.
69. Nomura M, Akama KT, Alves SE, et al.: Differential distribution of estrogen receptor (ER)-alpha and ER-beta in the midbrain raphe nuclei and periaqueductal gray in male mouse: Predominant role of ER-beta in midbrain serotonergic systems. Neuroscience 2005, 130:445-456.